CN205903334U - Coronary stent - Google Patents

Coronary stent Download PDF

Info

Publication number
CN205903334U
CN205903334U CN201620631090.9U CN201620631090U CN205903334U CN 205903334 U CN205903334 U CN 205903334U CN 201620631090 U CN201620631090 U CN 201620631090U CN 205903334 U CN205903334 U CN 205903334U
Authority
CN
China
Prior art keywords
coronary artery
rack body
glutin
myc
artery bracket
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201620631090.9U
Other languages
Chinese (zh)
Inventor
陈安勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201620631090.9U priority Critical patent/CN205903334U/en
Application granted granted Critical
Publication of CN205903334U publication Critical patent/CN205903334U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

The utility model discloses a coronary stent relates to medical intervention consumptive material field, which comprises a bracket body, the support body comprises closed wave unit, the crest and the trough department of wave unit all are equipped with omega shape connecting piece, be equipped with the bracing piece between wave unit, the middle part of bracing piece is equipped with the crooked connecting piece of W type, the support body outside is equipped with the glutin coating, is glutin coating surface equipped with C through adsorption myc antonymy string nucleotide layer, this kind of coronary stent is rational in infrastructure, high durability and convenient use, the coronary stent compliance that arrives through design like this is strong, radial holding power is good, axial transmitting force performance is good, is the adsorptivity of utilizing the glutin with C the permanent absorption of myc antonymy oligonucleotide on gelatin protein layer, C myc antonymy oligonucleotide releases at coronary artery blood vessel pathological change position gradually, performance anticoagulation and the effect that restraines the smooth muscle endometrial hyperplasia, reach and reduce in the art coronary artery acutely inaccessible and the mesh that prevents coronary artery postoperative restenosis for a long time.

Description

A kind of coronary artery bracket
Technical field
This utility model is related to medical intervention consumptive material field and in particular to a kind of coronary artery bracket.
Background technology
At present, China is considered as the most country of Patients with Cardiovascular/Cerebrovascular Diseases in the world, and its market potential enjoys medical treatment The favor of apparatus manufacturer.In the treatment of coronary heart disease, the coronary artery in infraction places an intravascular stent, i.e. a kind of implantation blood The metal mesh opening tubular device in pipe Stenotic pathologic change area, makes blood flow become unimpeded, is presently the most effective and conventional treatment Method, the clinical efficacy of stent in the treatment coronary heart disease is obvious to all, but it also has shortcoming, and support is after implantation during 6-8 month May occur in which in-stent restenosis, that is, occur blocking again, the incidence rate about 20% of metal rack age restenosiss, existing heart props up The tinsel that frame is mostly rhombus grid structure is constituted, and also there is compliance, radial support power and transmitting axle force performance bad Problem, and the cardiac stent blood vessel contact area of diamond structure is uniformly, stress is less, be subject in the blood vessel blood flow effect or The impact of person's human body aggravating activities easily causes displacement, it could even be possible to falling into ventricle, seriously threatens patient health.
Utility model content
The purpose of this utility model is to provide a kind of coronary artery bracket, above-mentioned multinomial is lacked with solve to lead in prior art Fall into.
A kind of coronary artery bracket, including rack body, described rack body is made up of the waveform unit closing, described wave It is equipped with ω shape connector at the crest of shape unit and trough, be provided with 2-3 trough or crest between described waveform unit Support bar, the middle part of described support bar is provided with the w type flex connector of horizontal stroke, and the middle-end of described w type flex connector is longer than two ends 1-2mm, the axial direction between each waveform unit connects through support bar and realizes, and is provided with glutin and applies outside described rack body Layer, described gelatin coated surface is provided with c-myc antisense oligonucleotides layer by adsorption.
Preferably, described rack body is Nitinol.
Preferably, described rack body medial surface is provided with a nanometer silver coating, and described nanometer silver coating surface is provided with heparin layer.
Preferably, the middle-end of the described w type flex connector part longer than two ends is provided with metal carbonyl coat.
Preferably, described metal carbonyl coat is stiff cochrome material.
The utility model has the advantage of: rational in infrastructure, easy to use, material therefor good biocompatibility, through so The coronary artery bracket compliance arriving of design is strong, and radial support power is good, transmitting axle force excellent performance, and the adsorptivity using glutin will , on glutin layer, c-myc antisense oligonucleotide is at coronary lesions position for the permanent absorption of c-myc antisense oligonucleotide Gradually discharge, play anticoagulation and the effect of the smooth myointimal hyperplasia of suppression, reach in minimizing art arteria coronaria acute occlusion and permanent Prevent the purpose of arteria coronaria postoperative restenosis, the use of nano coating can reduce the adventitious deposit of lipid, heparin layer can dissolve Small thrombosis in blood, the design of metal carbonyl coat makes the front end of w type flex connector bend to tubulose in rack body When have certain protrusion angles, can contact with internal blood vessel, increase stress between the two, crystallized ability is strong, effectively prevent The problem that cardiac stent easily shifts under various conditions.
Brief description
Structural representation when Fig. 1 launches for this utility model.
Fig. 2 is the structural representation of section of the present utility model.
Wherein: 1 rack body, 2 waveform units, 3 ω shape connectors, 4 support bars, 5 w type bendings connect Part, 6 gelatin coateds, 7 c-myc antisense oligonucleotides layers, 8 nanometers of silver coatings, 9 heparin layers, 10 metal bags Coating.
Specific embodiment
Technological means, creation characteristic, reached purpose and effect for making this utility model realize are easy to understand, below In conjunction with specific embodiment, this utility model is expanded on further.
As shown in Figure 1 and Figure 2, a kind of coronary artery bracket, including rack body 1, described rack body 1 is by the waveform closing Unit 2 forms, and is equipped with ω shape connector 3 at the crest of described waveform unit 2 and trough, between described waveform unit 2 It is provided with support bar 4, the middle part of described support bar 4 is provided with the w type flex connector 5 of horizontal stroke, described w type at 2-3 trough or crest The middle-end 1-2mm longer than two ends of flex connector 5, the axial direction between each waveform unit 2 connects through support bar 4 and realizes, institute State and outside rack body 1, be provided with gelatin coated 6, it is anti-that described gelatin coated 6 surface is provided with c-myc by adsorption Justice hangs nucleoside acid layer 7, and strong through the coronary artery bracket compliance arriving of such design, radial support power is good, transmitting axle force excellent performance, Using glutin adsorptivity by absorption permanent for c-myc antisense oligonucleotide on glutin layer, c-myc antisense widow core Thuja acid gradually discharges at coronary lesions position, plays anticoagulation and the effect of the smooth myointimal hyperplasia of suppression, reaches minimizing Arteria coronaria acute occlusion and the purpose preventing arteria coronaria postoperative restenosis for a long time in art.
Wherein, described rack body 1 is Nitinol, good biocompatibility.
Particularly, described rack body 1 medial surface is provided with nanometer silver coating 8, and described nanometer silver coating 8 surface is provided with heparin Layer 9, the use of nano coating can reduce the adventitious deposit of lipid, and heparin layer can be with the small thrombosis in lysed blood.
It should be noted that the middle-end of described w type flex connector 5 part longer than two ends is provided with metal carbonyl coat 10, described metal carbonyl coat 10 is stiff cochrome material, and the design of metal carbonyl coat makes w type flex connector There are certain protrusion angles front end when rack body bends to tubulose, can contact with internal blood vessel, increase between the two should Power, crystallized ability is strong, effectively prevent the problem that cardiac stent easily shifts under various conditions.
Summary, this coronary artery bracket is rational in infrastructure, easy to use, submissive through the coronary artery bracket arriving of such design Property strong, radial support power is good, transmitting axle force excellent performance, and the adsorptivity using glutin will be permanent for c-myc antisense oligonucleotide Absorption on glutin layer, c-myc antisense oligonucleotide gradually discharges at coronary lesions position, play anticoagulation and The effect of the smooth myointimal hyperplasia of suppression, reaches arteria coronaria acute occlusion and the mesh preventing arteria coronaria postoperative restenosis for a long time in minimizing art 's.

Claims (5)

1. a kind of coronary artery bracket, including rack body it is characterised in that described rack body is by the waveform unit group closing Become, at the crest of described waveform unit and trough, be equipped with ω shape connector, between described waveform unit in 2-3 trough or It is provided with support bar, the middle part of described support bar is provided with the w type flex connector of horizontal stroke, in described w type flex connector at crest End is longer 1-2mm than two ends, and the axial direction between each waveform unit connects through support bar and realizes, and is provided with outside described rack body Gelatin coated, described gelatin coated surface is provided with c-myc antisense oligonucleotides layer by adsorption.
2. a kind of coronary artery bracket according to claim 1 it is characterised in that: described rack body be Nitinol.
3. a kind of coronary artery bracket according to claim 1 it is characterised in that: described rack body medial surface is provided with nanometer silver Coating, described nanometer silver coating surface is provided with heparin layer.
4. a kind of coronary artery bracket according to claim 1 it is characterised in that: the middle-end of described w type flex connector compares two Longer part is held to be provided with metal carbonyl coat.
5. a kind of coronary artery bracket according to claim 4 it is characterised in that: described metal carbonyl coat be stiff cobalt chromium Alloy material.
CN201620631090.9U 2016-06-24 2016-06-24 Coronary stent Expired - Fee Related CN205903334U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201620631090.9U CN205903334U (en) 2016-06-24 2016-06-24 Coronary stent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201620631090.9U CN205903334U (en) 2016-06-24 2016-06-24 Coronary stent

Publications (1)

Publication Number Publication Date
CN205903334U true CN205903334U (en) 2017-01-25

Family

ID=57813587

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201620631090.9U Expired - Fee Related CN205903334U (en) 2016-06-24 2016-06-24 Coronary stent

Country Status (1)

Country Link
CN (1) CN205903334U (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106580528A (en) * 2017-02-04 2017-04-26 成都鼎信致远科技有限公司 Coronary stent for preventing restenosis
CN108186175A (en) * 2018-02-02 2018-06-22 青岛市中心医院 A kind of novel and multifunctional Internal Medicine-Cardiovascular Dept. coronary artery bracket
WO2018188059A1 (en) * 2017-04-14 2018-10-18 深圳市方鹏科技有限公司 Blockage-proof inner core of fuel pipe of intelligent car
CN110785146A (en) * 2017-07-19 2020-02-11 雅培心血管系统公司 Intravascular stent

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106580528A (en) * 2017-02-04 2017-04-26 成都鼎信致远科技有限公司 Coronary stent for preventing restenosis
WO2018188059A1 (en) * 2017-04-14 2018-10-18 深圳市方鹏科技有限公司 Blockage-proof inner core of fuel pipe of intelligent car
CN110785146A (en) * 2017-07-19 2020-02-11 雅培心血管系统公司 Intravascular stent
CN108186175A (en) * 2018-02-02 2018-06-22 青岛市中心医院 A kind of novel and multifunctional Internal Medicine-Cardiovascular Dept. coronary artery bracket

Similar Documents

Publication Publication Date Title
CN205903334U (en) Coronary stent
US20210068991A1 (en) Anti-thrombogenic medical devices and methods
EP2326292B1 (en) Self-expanding medical device
EP1387704B1 (en) Monolayer modification to gold coated stents to reduce adsorption of protein
CN105934222B (en) Two-way bracket and the method for using the two-way bracket
JP2020192359A (en) Stent device having reduced foreshortening and recoil and method of making the same
JP2012523295A (en) Grafts with high fatigue resistance, graft delivery systems, and methods of use
CN106137484A (en) A kind of self-expansion type conical blood vessel support
WO2017012386A1 (en) Biodegradable metal vascular scaffold and use thereof
WO2020228440A1 (en) Blood vessel stent
CN103550017A (en) Intravascular stent applicable to conical blood vessel
CN201453427U (en) Intracranial artery support
CN2885176Y (en) A self-expanding vascular stent
CN202740162U (en) Novel vessel rack
CN204411043U (en) A kind of progressive thickness coronary artery bracket being applicable to the tortuous angulation pathological changes of coronary artery
CN203763305U (en) Coronary stent
CN216754738U (en) Wave-shaped intravascular stent
CN112618121B (en) Rapamycin drug eluting carotid artery stent
CN207168613U (en) A kind of intravascular stent
CN201213855Y (en) Tubular bracket for cavity channel
CN205163735U (en) Degradable support
TWI510225B (en) Stent
CN203493779U (en) Coronary vessel stent
TW201127354A (en) Preventing vascular stenosis of cardiovascular stent
CN107550611A (en) A kind of intravascular stent

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170125

Termination date: 20170624